These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 1846458

  • 1. Is there a link between cyclosporine A, altered cellular sodium transport, and arterial pressure in kidney transplant patients?
    Basolo B, Boero R, Guarena C, Forneris G, Formica M, Rollino C, Quarello F, Segoloni GP, Piccoli G.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1307-8. PubMed ID: 1846458
    [No Abstract] [Full Text] [Related]

  • 2. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J, Puig JM, Comerma I, Orfila A, Mir M, Masramón J, Aubia J.
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract] [Full Text] [Related]

  • 3. Activation of K+ channel and inhibition of Na(+)-K+ ATPase of human erythrocytes by cyclosporine: possible role in hyperpotassemia in kidney transplant recipients.
    Ihara H, Hosokawa S, Ogino T, Arima M, Ikoma F.
    Transplant Proc; 1990 Aug; 22(4):1736-9. PubMed ID: 2167529
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M, Barberato JB, Ramalho HJ, Saldanha LB, Casassanta DM, Denadai ER, Zerati S, Bezas AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract] [Full Text] [Related]

  • 7. Alteration of erythrocyte sodium transport in renal transplant recipients.
    Huang JY, Huang CC, Lau YT, Wu MS.
    Transplant Proc; 1996 Jun; 28(3):1609-10. PubMed ID: 8658806
    [No Abstract] [Full Text] [Related]

  • 8. Fractional excretion of sodium is an early predictor of cyclosporine nephrotoxicity after renal transplantation.
    Morales JM, Andrés A, Hernández E, Prieto C, Ortuño T, Montoyo C, Moreno F, Rodriguez-Paternina E, Farías J, Rodicio JL.
    Transplant Proc; 1990 Aug; 22(4):1728-9. PubMed ID: 2389444
    [No Abstract] [Full Text] [Related]

  • 9. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Florence-Green D, Norris C, Oh HK, Dienst S, Levin NW.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract] [Full Text] [Related]

  • 10. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N, Delaney V, Ding Z, Davis R, Butt K, Hong J.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract] [Full Text] [Related]

  • 11. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 12. [Kidney transplantation: the end of classical immunosuppression with azathioprine?].
    Gonnermann D, Huland H, Kraemer-Hansen H, Klosterhalfen H.
    Dtsch Med Wochenschr; 1984 Nov 02; 109(44):1689-91. PubMed ID: 6386420
    [No Abstract] [Full Text] [Related]

  • 13. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Transplant Proc; 1988 Jun 02; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract] [Full Text] [Related]

  • 14. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 15. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
    Mieny CJ, Nel PJ, Becker JH, Pretorius JP.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1852. PubMed ID: 3079049
    [No Abstract] [Full Text] [Related]

  • 16. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT, Rovelli M, Roper L, Bartus SA.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS, Veremis SA, Pollak R, Mozes MF.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov 02; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.